The World Mitochondria Society is organizing its 14th world conference, Targeting Mitochondria 2023, on October 11-13 at the Steigenberger Hotel Am Kanzleramt, Berlin. Targeting Mitochondria 2023 will address the latest advances and perspectives in mitochondrial research and provide an outlook on future mitochondrial therapies.
Volkmar Weissig, president of the World Mitochondria Society, and Marvin Edeas, president of the scientific committee, said, "This year we will have specific sessions on innovations such as mitochondria in space, exosome-based mitochondrial medicine, mitochondria transplantation and many other topics. Targeting Mitochondria will not only showcase the latest advances, but also highlight the latest strategies to take clinical translation to a new level."
Targeting Mitochondria 2023 Sessions
The congress will be an opportunity to learn more and exchange about:
Among WMS Annual Meeting 2023 Speakers
Defining the molecular nature of the mitochondrial permeability transition pore(s) – Paolo Bernardi, the University of Padova, Italy
Protein Transport across Mitochondrial Membranes – Peter Rehling, University Medical Center Göttingen, Germany
What spaceflight and bed rest have in common: A proteomic point of view – Marta Murgia, University of Padova, Italy
The Role of Mitochondria in Liver Regeneration – Jiri Neuzil, Griffith University, Australia
Exogenous Mitochondrial Internalization for Corneal Dystrophy TreatmentInternalization of Exogenous Mitochondria for Endothelial Corneal Dystrophy Treatment – Patrick J. Rochette, Université Laval, Canada
Mitochondrial Stress as a Central Biological Hub for Spaceflight Impact – Afshin Beheshti, NASA Ames Research Center, USA
Repairing Marginal Kidneys with Mitochondrial Transplantation: A New Powerful Tissue Engineering Tool That Will Change the Transplant Landscape – Giuseppe Orlando, Wake Forest University, USA
Mitochondria Organelle Transplantation for Neurological Diseases and Aging – Mark S. Kindy, University of South Florida, USA
Cardiac MitoMed: From Bench to BedsideCardiac MitoMed: From Bench to Bedside – Sang-Bing Ong, The Chinese University of Hong Kong, China
Restoration of Mitochondrial Homeostasis provides Glaucoma Neuroprotection – Arupratan Das, Indiana University School of Medicine, USA
Personalized Medicine in Mitochondrial Health and Disease: Myth and Reality – Ciro Leonardo Perri, the University of Bari Aldo Moro, Italy
Innovations & Abstracts Submission
You can share your innovations and latest discoveries in front of international mitochondria experts and academics.
Among the abstracts and innovations submitted, the World Mitochondria Society will discern 4 awards at the end of Targeting Mitochondria 2023:
About the World Mitochondria Society
The World Mitochondria Society emerged seamlessly out of a series of yearly conferences organized since 2010 by the International Society of Antioxidants in Nutrition and Health. The current president of the WMS is Volkmar Weissig, Midwestern University, College of Pharmacy Glendale, USA.
Scientific committee of the World Mitochondria Society
President Volkmar Weissig, Midwestern University, College of Pharmacy Glendale, USA
Founder Marvin Edeas, Institut Cochin, INSERM 1016, Université de Paris, France
Eric Barrey, INRA, France
Martin Bergö, Karolinska Instuitutet, Sweden
Laurent Chatre, CNRS, Université de Caen-Normandie, France
Carsten Culmsee, Magburg University, Germany
Frank Gellerich, Otto-von-Guericke-University, Germany
Vladimir Gogvadze, Karolinska Institutet, Sweden
Naïg Gueguen, MitoVasc Institute, Angers University Hospital Center, France
Ian Holt, Instituto de Investigación Sanitaria Biodonostia, Spain
Devika Manickam, Duquesne University, USA
James McCully, Harvard Medical School, USA
Egbert Mik, Erasmus MC, The Netherlands
Maik Hüttemann, Wayne State University School of Medicine, USA
Carole Nicco, Institut Cochin - INSERM U1016, Université Paris Descartes, France
Nicole Noren Hooten, National Institutes of Health, USA
Alessandro Prigione, Max Delbrueck Center for Molecular Medicine, Germany
Miria Ricchetti, Institut Pasteur, France
Ivan Tarassov, Labex MitoCross, France
Hans Zischka, Institute of Molecular Toxicology and Pharmacology, Germany